SearchDictionaryMobileLogin

Lymph Node Tuberculosis (Scrofula)

174  relevant articles (5 outcomes, 14 trials/studies) found for this Disease

Description: Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.

Also Known As:
Scrofula; Tuberculosis, Lymph Node; Cervical Lymphadenitis, Mycobacterial; Lymph Node Tuberculoses; Lymphadenitis, Cervical Tuberculous; Lymphadenitis, Mycobacterial Cervical; Scrofulas; Tuberculoses, Lymph Node; Tuberculous Lymphadenitis; Tuberculous Lymphadenitis, Cervical; Cervical Tuberculous Lymphadenitis; Lymphadenitis, Tuberculous; Mycobacterial Cervical Lymphadenitis

Relationship Network

Disease Context: Research Results

Related Diseases

1. Tuberculosis
2. Infection
3. Pleural Effusion (Pleural Effusions)
4. Erythema Induratum (Bazin Disease)
5. Pulmonary Tuberculosis

Experts

1. Mustafa, Tehmina: 4 articles (09/2008 - 02/2005)
2. Sviland, Lisbet: 4 articles (09/2008 - 02/2005)
3. Mørkve, Odd: 3 articles (01/2007 - 02/2005)
4. Budhwar, Puja: 2 articles (07/2008 - 07/2006)
5. Goel, Madhu Mati: 2 articles (07/2008 - 07/2006)
6. Mogga, Stanley J: 2 articles (04/2006 - 02/2005)
7. Mfinanga, Sayoki G M: 2 articles (04/2006 - 02/2005)
8. Purohit, Manju Raj: 1 article (09/2008)
9. Somekh, Eli: 1 article (08/2007)
10. Feinberg, Jacqueline: 1 article (08/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lymph Node Tuberculosis:
1. Tuberculin (PPD)IBA
2. Sepharose (Agarose)IBA
3. Rifampin (Rifampicin)FDA LinkGeneric
4. AntigensIBA
5. Isoniazid (Ftivazide)FDA LinkGeneric
6. DNA (Deoxyribonucleic Acid)IBA
7. PyrazinamideFDA LinkGeneric
02/01/2002 - "METHODS: An observational trial was conducted to determine the effectiveness of a completely DOT 6-month regimen for pulmonary, pleural and lymph node tuberculosis in children with the use of 2 weeks of daily isoniazid, rifampin and pyrazinamide therapy; then 6 weeks of twice weekly isoniazid, rifampin and pyrazinamide therapy; followed by 16 weeks of twice weekly isoniazid and rifampin. "
11/01/2005 - "METHODS: Patients with biopsy confirmed superficial lymph node tuberculosis were randomly allocated to receive either a daily self-administered 6-month regimen of rifampicin and isoniazid, or a twice-weekly, directly observed, 6-month regimen of rifampicin and isoniazid plus pyrazinamide for the first 2 months, in Madurai, South India, Patients were followed up for 36 months after completing treatment. "
11/01/2005 - "OBJECTIVE: The currently recommended treatment for lymph node tuberculosis is 6 months of rifampicin and isoniazid plus pyrazinamide for the first 2 months, given either daily or thrice weekly. "
06/01/1994 - "There was a history of mediastinal tuberculous lymphadenitis 3 years earlier that was treated with isoniazide, rifampin, ethambutol, and pyrazinamide for 2 years. "
02/01/2000 - "The Revised National Tuberculosis Control Programme recommends that patients with lymph node tuberculosis (Category 3) should be treated with rifampicin and isoniazid three times a week for six months, with pyrazinamide for the first two months."
Order ALL the reference details at left...
8. tebufenozide (Mimic)IBA
9. Interferon-gamma (Interferon, gamma)IBA
10. butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
3. Aftercare (After-Treatment)
4. Laparotomy
5. Neck Dissection (Radical Neck Dissection)

Best Treatments:
Research Summary Report
on Lymph Node Tuberculosis
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 5 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>